Todd C. Brady, President and CEO at Aldeyra Therapeutics, Inc. (ALDX), bought 20,000 shares at $5.39 ($103K) on 2019-09-10, disclosed to the SEC on 2019-09-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.89 | 10,000 | $49K | 47.6% |
| 2 | $5.39 | 10,000 | $54K | 52.4% |
| Total | $5.14 avg | 20,000 | $103K | 100% |
| Filing → |
| ALDX | BUY | 2022-06-27 | $59K | — | Filing → |
| ALDX | BUY | 2019-12-18 | $102K | — | Filing → |
| ALDX | BUY | 2019-10-02 | $49K | — | Filing → |